Back

Prognostic value of 99mTc-pyrophosphate uptake in patients with suspected transthyretin cardiac amyloidosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Multimodality imaging of the myocardium Imaging of Heart Failure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Tomohi Ajima

Juntendo University Shizuoka Hospital, Izunokuni (Japan)

6 More presentations in this session

Presentation thumbnail
Discordant findings on stress cardiac magnetic resonance imaging and invasive coronary angiography are associated with left ventricular mass
Doctor K. Kader (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
A deep learning model to score Tc-99m PYP uptake in patients with suspected ATTR-CM
Mr D. Ou (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Pathophysiologic implications of three-dimensional left ventricular longitudinal strain-volume loops in hypertrophic cardiomyopathy.
Doctor E. Pagourelias (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Multiparametric prediction of left ventricular adverse remodeling after myocardial infarction: a machine learning-based comparison of segmental strain and clinical risk factors
Doctor X. A (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Temporal trends in first-line diagnostic testing for heart failure etiology in patients with new-onset heart failure and low pre-test probability of coronary artery disease
Doctor C. Graversen (Herning, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Multimodality imaging of the myocardium

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Pyrophosphate scintigram as a potential imaging index of therapeutic efficacy for transthyretin cardiac amyloidosis
thumbnail
Congress Session
Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment
thumbnail
Congress Presentation
Cardiac transthyretin amyloidosis in patients with conduction system disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources